Peder Myhre

Sep 2, 2024 | onlinelibrary.wiley.com | Peder Myhre |Kristian Berge |Stein Ørn

Letter to the Editor Reply to the letter regarding the article ‘Changes in 6-min walk test is an independent predictor of death in chronic heart failure with reduced ejection fraction’ Peder L. Myhre,  Corresponding Author Peder L. Myhre Department of Cardiology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway K.G. Jebsen Center for Cardiac Biomarkers, Institute of Clinical Medicine, University of Oslo, Oslo, Norway Corresponding author.

Mar 1, 2024 | jacc.org | Peder Myhre |Carolyn S.P. Lam

References1. "Angiotensin-neprilysin inhibition versus enalapril in heart failure". N Engl J Med . 2014;371:11: 993-1004. 2. "Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure". N Engl J Med . 2018;380:6: 539-548. 3. "Early adoption of sacubitril/valsartan for patients with heart failure with reduced ejection fraction: insights from Get With the Guidelines–Heart Failure (GWTG-HF)". J Am Coll Cardiol HF . 2017;5:4: 305-309. 4.

Nov 17, 2023 | mdpi.com | Peder Myhre |Thomas A. Zelniker |Marco Metra |Mauro Riccardi

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Jul 4, 2023 | onlinelibrary.wiley.com | Peder Myhre |Yuxi Liu |Ian J. Kulac |Brian Claggett

ABSTRACT Background Adrenomedullin is a vasodilatory peptide with a role in microcirculatory and endothelial homeostasis. Adrenomedullin is a substrate for neprilysin and may therefore play a role in beneficial effects of sacubitril/valsartan (Sac/Val) treatment.